Corona Remedies Ltd vs Innova Captab Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 11, 2026

Key Highlights

The Latest Trading Price of Corona Remedies Ltd is ₹ 1580 as of 19 Feb 10:41 . The P/E Ratio of Corona Remedies Ltd changed from 0 on March 2023 to 0 on March 2022 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Innova Captab Ltd changed from 27.2 on March 2024 to 0 on March 2022 . This represents a CAGR of -100.00% over 4 years The Market Cap of Corona Remedies Ltd changed from ₹ 0 crore on March 2023 to ₹ 0 crore on March 2022 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Innova Captab Ltd changed from ₹ 2564 crore on March 2024 to ₹ 0 crore on March 2022 . This represents a CAGR of -100.00% over 4 years The revenue of Corona Remedies Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 344.68 crore. This represent the decline of -100% The revenue of Innova Captab Ltd for the Mar '26 is ₹ 449.37 crore as compare to the Dec '25 revenue of ₹ 451.95 crore. This represent the decline of -0.57% The ebitda of Corona Remedies Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 66.32 crore. This represent the decline of -100% The ebitda of Innova Captab Ltd for the Mar '26 is ₹ 66.66 crore as compare to the Dec '25 ebitda of ₹ 71.05 crore. This represent the decline of -6.18% The net profit of Corona Remedies Ltd changed from ₹ 29.95 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of Innova Captab Ltd changed from ₹ 29.48 crore to ₹ 38.08 crore over 8 quarters. This represents a CAGR of 13.65% The Dividend Payout of Corona Remedies Ltd changed from 20 % on March 2023 to 30 % on March 2025 . This represents a CAGR of 14.47% over 3 yearsThe Dividend Payout of Innova Captab Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Corona Remedies Ltd

Corona Remedies Limited was originally incorporated as CORONA Remedies Private Limited', a private limited company, dated August 27, 2004, issued by the Assistant Registrar of Companies, Gujarat at Dadra and Nagar Haveli.
Thereafter, Company converted into a public limited and Company name has changed to CORONA Remedies Limited'.
A fresh certificate of incorporation, is issued by the Registrar of Companies, Central Processing Centre, Manesar, Haryana on December 16, 2024. The manufacturing facilities of the Company are located at Solan (Himachal Pradesh) and at Bhayla (Ahmedabad, Gujarat).
The Company is engaged in manufacturing, trading and marketing of Pharmaceutical products in women's healthcare, cardio-diabeto, pain management, urology and other therapeutic areas. In 2004, Company launched the first division, and later named it as Pioneer' division in year 2010; launched Xemx (multispeciality) division in 2005.

About Innova Captab Ltd

Innova Captab Limited was incorporated as Harun Health Care Private Limited', dated January 3, 2005, as a Private Limited Company at Mumbai.
Thereafter, the name of the Company was changed from Harun Health Care Private Limited' to Innova Captab Private Limited', and a fresh Certificate of Incorporation dated February 2, 2010, was issued by RoC to the Company.
Subsequently, Company got converted to a Public Company on July 12, 2018, and the name was changed to Innova Captab Limited', dated July 26, 2018. The Company is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain including research and development, manufacturing, drug distribution and marketing and exports.
Their business includes contract development and manufacturing organization (CDMO) business providing manufacturing services to Indian pharmaceutical companies, domestic branded generics business and an international branded generics business.

FAQs for the comparison of Corona Remedies Ltd and Innova Captab Ltd

Which company has a larger market capitalization, Corona Remedies Ltd or Innova Captab Ltd?

Market cap of Corona Remedies Ltd is 10,471 Cr while Market cap of Innova Captab Ltd is 5,009 Cr

What are the key factors driving the stock performance of Corona Remedies Ltd and Innova Captab Ltd?

The stock performance of Corona Remedies Ltd and Innova Captab Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Corona Remedies Ltd and Innova Captab Ltd?

As of May 11, 2026, the Corona Remedies Ltd stock price is INR ₹1712.15. On the other hand, Innova Captab Ltd stock price is INR ₹875.45.

How do dividend payouts of Corona Remedies Ltd and Innova Captab Ltd compare?

To compare the dividend payouts of Corona Remedies Ltd and Innova Captab Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.